--- title: "Cannabis News & Politik 2026: Legalisierung, KCanG, Studien (English) | HighSpace" description: "English edition — Aktuelle Nachrichten zu Cannabis in Deutschland: Legalisierung, Gesetzesänderungen, Medizin-Studien und internationale Entwicklungen." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "Organization", "name": "HighSpace", "url": "https://high.space", "logo": "https://high.space/og-image.jpg", "description": "HighSpace ist das deutsche Cannabis-Portal: Strain-Reviews, Telemedizin-Vergleich, Marken, Guides, Rezepte und News zur Legalisierung.", "inLanguage": "de" }, { "@context": "https://schema.org", "@type": "WebSite", "name": "HighSpace", "url": "https://high.space", "inLanguage": "de", "publisher": { "@type": "Organization", "name": "HighSpace", "url": "https://high.space" }, "potentialAction": { "@type": "SearchAction", "target": "https://high.space/strains?q={search_term_string}", "query-input": "required name=search_term_string" } }, { "@context": "https://schema.org", "@type": "CollectionPage", "name": "Cannabis News & Politik", "description": "Aktuelle Nachrichten zu Cannabis-Legalisierung, Medizin und Politik in Deutschland.", "url": "https://high.space/news", "inLanguage": "de", "isPartOf": { "@type": "WebSite", "name": "HighSpace", "url": "https://high.space" }, "hasPart": [ { "@type": "NewsArticle", "headline": "Vorrang für Fertigarzneimittel: Wie der Bundestag Cannabis-Patienten opfert — und warum kaum jemand spart", "url": "https://high.space/news/gkv-vorrangregelung-cannabis-fertigarzneimittel-bundestag", "datePublished": "2026-07-10", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "Streeck überrascht: CDU-Drogenbeauftragter offen für legalen Cannabis-Verkauf in Modellprojekten", "url": "https://high.space/news/streeck-offen-fuer-cannabis-modellprojekte", "datePublished": "2026-05-29", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "Modellprojekte: Was die Schweiz mit Grashaus vormacht — und warum Deutschland sich selbst blockiert", "url": "https://high.space/news/cannabis-modellprojekte-schweiz-deutschland", "datePublished": "2026-05-04", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "Cannabisblüten auf der Streichliste: Wie das Kabinett die GKV-Erstattung kippen will — und was der Bundestag noch ändern kann", "url": "https://high.space/news/gkv-cannabisblueten-erstattung-kabinettsentwurf", "datePublished": "2026-04-29", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "Dobrindt vs. Wissenschaft: Wie der Innenminister den EKOCAN-Bericht diskreditiert — und die Forscher sich wehren", "url": "https://high.space/news/dobrindt-attackiert-ekocan-forscher", "datePublished": "2026-04-10", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "EKOCAN-Zwischenbericht 2026: Was das Cannabisgesetz wirklich verändert hat", "url": "https://high.space/news/ekocan-zwischenbericht-2026", "datePublished": "2026-04-02", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "SPD lehnt MedCanG-Änderung ab: Was das für Patienten bedeutet", "url": "https://high.space/news/spd-gegen-medcang-aenderung", "datePublished": "2026-03-15", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "USA: Trump stuft Cannabis auf Schedule III um — historische Wende", "url": "https://high.space/news/usa-cannabis-reklassifizierung-trump", "datePublished": "2026-01-10", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "Cannabis-Legalisierung in der Schweiz: Der Weg zum regulierten Markt", "url": "https://high.space/news/schweiz-cannabis-legalisierung-prozess", "datePublished": "2026-02-20", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "Grashaus Projects: Wie legaler Cannabis-Verkauf in der Schweiz funktioniert", "url": "https://high.space/news/grashaus-projects-pilotprojekt-schweiz", "datePublished": "2026-02-10", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "CanG 2.0: Was sich 2025 für Patienten und Konsumenten ändert", "url": "https://high.space/news/cannabis-gesetz-2025-aenderungen", "datePublished": "2025-04-02", "author": { "@type": "Person", "name": "Redaktion" } }, { "@type": "NewsArticle", "headline": "Charité-Studie: CBD bei chronischen Schmerzen wirksamer als gedacht", "url": "https://high.space/news/charite-studie-cbd-chronische-schmerzen", "datePublished": "2025-03-28", "author": { "@type": "Person", "name": "Dr. M. Weber" } }, { "@type": "NewsArticle", "headline": "Cannabis-Apotheken im Vergleich: Preise, Sortiment & Lieferzeiten", "url": "https://high.space/news/cannabis-apotheken-vergleich-2025", "datePublished": "2025-03-22", "author": { "@type": "Person", "name": "J. Hoffmann" } }, { "@type": "NewsArticle", "headline": "Cannabis Social Clubs: Erste Vereine starten den Anbau", "url": "https://high.space/news/cannabis-social-clubs-erste-genehmigungen", "datePublished": "2025-03-15", "author": { "@type": "Person", "name": "L. Fischer" } }, { "@type": "NewsArticle", "headline": "Cannabis und ADHS: Neue Leitlinien der Fachgesellschaft", "url": "https://high.space/news/cannabis-adhs-neue-leitlinien", "datePublished": "2025-03-10", "author": { "@type": "Person", "name": "Dr. K. Müller" } }, { "@type": "NewsArticle", "headline": "EU-Parlament debattiert einheitliche Cannabis-Regulierung", "url": "https://high.space/news/eu-cannabis-regulierung-2025", "datePublished": "2025-03-05", "author": { "@type": "Person", "name": "Redaktion" } } ] }, { "@context": "https://schema.org", "@type": "Organization", "name": "HighSpace", "url": "https://high.space", "logo": { "@type": "ImageObject", "url": "https://high.space/og-image.jpg" }, "description": "HighSpace ist das deutsche Cannabis-Portal: Telemedizin-Vergleich, Strain Reviews, Marken, Guides und News zur Legalisierung.", "inLanguage": "de", "sameAs": [] }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Start", "item": "https://high.space/" }, { "@type": "ListItem", "position": 2, "name": "News & Politik", "item": "https://high.space/news" } ] }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Welche Cannabis-News findest du auf HighSpace?", "acceptedAnswer": { "@type": "Answer", "text": "Wir berichten über die deutsche Legalisierung (KCanG, MedCanG), politische Entwicklungen, Studien aus der Cannabismedizin, Marktbewegungen sowie internationale Trends aus der EU, der Schweiz und den USA." } }, { "@type": "Question", "name": "Wie aktuell sind die Inhalte?", "acceptedAnswer": { "@type": "Answer", "text": "Die Redaktion veröffentlicht mehrfach pro Woche neue Artikel und aktualisiert bestehende Beiträge bei wichtigen Gesetzesänderungen oder neuen Studienergebnissen. Das Datum der letzten Änderung ist in den Strukturdaten jedes Artikels hinterlegt." } }, { "@type": "Question", "name": "Sind die Artikel unabhängig?", "acceptedAnswer": { "@type": "Answer", "text": "Ja. HighSpace ist redaktionell unabhängig. Quellen werden offengelegt, kommerzielle Kooperationen werden im Beitrag transparent gekennzeichnet." } } ] } ] --- [![HighSpace – Cannabis-Portal](/assets/highspace-logo-bN0aW_BL.webp)](/en) [Brands](/en/marken)[Cannabis Sommelier](/en/cannabis-sommelier)[Strains](/en/strains)[Product Finder](/en/produkt-finder)[Guide](/en/guide)[Recipes](/en/rezepte)[News & Politics](/en/news)[Tools](/en/tools)[Become a patient](/en/patient-werden) en en Machine-translated from German. The original is the source of truth. 1. [Home ](/en) 2. News & Politics Legalization · Research · Market # News & Politics Everything important from the world of cannabis — from laws and studies to market developments. AllLegalizationMedicineMarketInternationalPolitics [ ![Preference for finished medicinal products: How the Bundestag sacrifices cannabis patients — and why hardly anyone saves](/assets/gkv-fertigarzneimittel-vorrang-DS9QX6YX.jpg) Politics ## Preference for Finished Medicinal Products: How the Bundestag Sacrifices Cannabis Patients — and Why Hardly Anyone Saves July 10, 2026 · Editorial Staff · 11 Min. The Bundestag has decided on a priority regulation for cannabis finished medicinal products in the GKV savings law. Flowers and pharmacy-made preparations are relegated to the end of the prescription chain. The hemp association calls it "scandalous", the Pharmazeutische Zeitung a "foreign body in the savings law". An analysis — critical, from a patient's perspective, with figures. Read more → ](/en/news/gkv-vorrangregelung-cannabis-fertigarzneimittel-bundestag) [ ![Streeck surprised: CDU drug commissioner open to legal cannabis sales in pilot projects](/assets/streeck-pilotprojekte-Itk5wjJq.jpg) Politics ### Streeck Surprised: CDU Drug Commissioner Open to Legal Cannabis Sales in Pilot Projects May 29, 2026 · 8 Min. Hendrik Streeck (CDU), the federal government's drug commissioner, is the first CDU politician to advocate for pilot projects for legal cannabis sales — against his party's line. His argument: This is the only way to close the supply gap and relieve pressure on medical prescriptions. Read more → ](/en/news/streeck-offen-fuer-cannabis-modellprojekte)[ ![Pilot projects: What Switzerland is demonstrating with Grashaus — and why Germany is blocking itself](/assets/modellprojekte-U4fww5bQ.jpg) Politics ### Pilot Projects: What Switzerland is Demonstrating with Grashaus — and Why Germany is Blocking Itself May 4, 2026 · 10 Min. With Grashaus Projects in Baselland, Sanity Group operates one of Europe's most successful cannabis pilot projects. In Germany, Pillar 2 failed, the traffic light coalition's research regulation is in force — but the BLE rejects all applications. Now, of all people, CDU drug commissioner Hendrik Streeck is calling for pilot projects. Read more → ](/en/news/cannabis-modellprojekte-schweiz-deutschland)[ ![Cannabis flowers on the chopping block: How the Cabinet wants to scrap GKV reimbursement — and what the Bundestag can still change](/assets/gkv-blueten-DZwK-lpM.jpg) Politics ### Cannabis Flowers on the Chopping Block: How the Cabinet Wants to Scrap GKV Reimbursement — and What the Bundestag Can Still Change April 29, 2026 · 9 Min. With the GKV Contribution Rate Stabilization Act, the Federal Cabinet decided on April 29, 2026, to remove cannabis flowers from reimbursement by statutory health insurance. This is expected to save 100 to 150 million euros annually. Associations are up in arms — and the Bundestag still has to decide. Read more → ](/en/news/gkv-cannabisblueten-erstattung-kabinettsentwurf)[ ![Dobrindt vs. Science: How the Interior Minister discredits the EKOCAN report — and how researchers fight back](/assets/dobrindt-ekocan-hTWE-qTU.jpg) Politics ### Dobrindt vs. Science: How the Interior Minister Discredits the EKOCAN Report — and How Researchers Fight Back April 10, 2026 · 9 Min. Federal Interior Minister Dobrindt accuses EKOCAN researchers of a 'distorted picture'. The scientists retort: He apparently hasn't read the report. A commentary on the freedom of research. Read more → ](/en/news/dobrindt-attackiert-ekocan-forscher)[ ![EKOCAN Interim Report 2026: What the Cannabis Act really changed](/assets/ekocan-report-Byo2Guen.jpg) Politics ### EKOCAN Interim Report 2026: What the Cannabis Act Really Changed April 2, 2026 · 10 Min. The second interim report of the EKOCAN evaluation provides extensive data for the first time: no increase in youth consumption, fewer criminal proceedings, but sluggish social clubs and a booming medical cannabis market. Read more → ](/en/news/ekocan-zwischenbericht-2026)[ ![SPD rejects MedCanG amendment: What this means for patients](/assets/spd-medcang-39tDPYfR.jpg) Politics ### SPD Rejects MedCanG Amendment: What This Means for Patients March 15, 2026 · 8 Min. The SPD clearly opposes the planned tightening of the Medical Cannabis Act. Carmen Wegge rejects the telemedicine ban and the mail-order ban 'under no circumstances'. Read more → ](/en/news/spd-gegen-medcang-aenderung)[ ![USA: Trump reclassifies cannabis to Schedule III — historical turning point](/assets/usa-reclassification-D9Yf-ESY.jpg) International ### USA: Trump Reclassifies Cannabis to Schedule III — Historic Turning Point January 10, 2026 · 9 Min. By executive order, Trump is accelerating the reclassification of cannabis from Schedule I to Schedule III. The effects on taxes, research, and banking are enormous — also for Europe. Read more → ](/en/news/usa-cannabis-reklassifizierung-trump)[ ![Cannabis legalization in Switzerland: The path to a regulated market](/assets/schweiz-legalisierung-J-EofnmV.jpg) International ### Cannabis Legalization in Switzerland: The Path to a Regulated Market February 20, 2026 · 8 Min. Switzerland is planning licensed specialist shops instead of social clubs. After pilot projects and consultation, a regulated cannabis market could emerge from 2028. Read more → ](/en/news/schweiz-cannabis-legalisierung-prozess)[ ![Grashaus Projects: How legal cannabis sales work in Switzerland](/assets/grashaus-projects-mMC1oj_b.jpg) International ### Grashaus Projects: How Legal Cannabis Sales Work in Switzerland February 10, 2026 · 7 Min. After more than two years, the pilot project in Basel-Landschaft shows: regulated specialized trade strengthens health protection, increases consumption competence, and displaces the black market. Read more → ](/en/news/grashaus-projects-pilotprojekt-schweiz)[ ![CanG 2.0: What changes for patients and consumers in 2025](/assets/cannabis-gesetz-Dwvk0Vyu.jpg) Legalization ### CanG 2.0: What Changes for Patients and Consumers in 2025 April 2, 2025 · 8 Min. One year after partial legalization, the federal government takes stock and announces improvements. We summarize the most important changes. Read more → ](/en/news/cannabis-gesetz-2025-aenderungen)[ ![Charité study: CBD more effective than expected for chronic pain](/assets/cbd-studie-C-rreLE9.jpg) Medicine ### Charité Study: CBD More Effective Than Expected for Chronic Pain March 28, 2025 · 6 Min. Researchers at Charité Berlin publish promising results from a long-term study on treating chronic pain patients with cannabidiol. Read more → ](/en/news/charite-studie-cbd-chronische-schmerzen)[ ![Cannabis pharmacies compared: Prices, assortment & delivery times](/assets/apotheken-CRmiAymF.jpg) Market ### Cannabis Pharmacies Compared: Prices, Assortment & Delivery Times March 22, 2025 · 10 Min. We tested the largest online pharmacies with a cannabis assortment. A comprehensive overview of prices, availability, and service. Read more → ](/en/news/cannabis-apotheken-vergleich-2025)[ ![Cannabis Social Clubs: First clubs start cultivation](/assets/social-clubs-B25gb_tw.jpg) Legalization ### Cannabis Social Clubs: First Clubs Start Cultivation March 15, 2025 · 7 Min. In several federal states, the first Cannabis Social Clubs have received their licenses and are beginning collective cultivation. Read more → ](/en/news/cannabis-social-clubs-erste-genehmigungen)[ ![Cannabis and ADHD: New guidelines from the professional society](/assets/adhs-e_Muuiwm.jpg) Medicine ### Cannabis and ADHD: New Guidelines from the Professional Society March 10, 2025 · 6 Min. The German Society for Psychiatry has published the first evidence-based guidelines for the therapeutic use of cannabis for ADHD. Read more → ](/en/news/cannabis-adhs-neue-leitlinien)[ ![EU Parliament debates uniform cannabis regulation](/assets/eu-regulierung-_gciCAfT.jpg) International ### EU Parliament Debates Uniform Cannabis Regulation March 5, 2025 · 8 Min. After legalizations in Germany, Malta, and Luxembourg, a majority in the EU Parliament is calling for common standards for the cannabis market for the first time. Read more → ](/en/news/eu-cannabis-regulierung-2025) ## Discover more [Strain Reviews All avaay strains at a glance ](/en/strains)[Cannabis Brands The most important manufacturers ](/en/marken)[Cannabis Sommelier Toking Tim in portrait ](/en/cannabis-sommelier) ## Do you want cannabis as medicine? Find the right telemedicine provider and start your therapy today. [Become a patient now →](/en/patient-werden) [![HighSpace – Cannabis-Portal](/assets/highspace-logo-bN0aW_BL.webp)](/en) Your space. Your cannabis. The German portal for medical cannabis. GermanEnglishTurkish For patients - [Telemedicine providers](/en/patient-werden) - [Product Finder](/en/produkt-finder) - [Strain reviews](/en/strains) - [Cannabis brands](/en/marken) - [Baltic information](https://villa-boreal.de) - [Atlantic information](https://villa-austral.com) - [Cannabisrezept.online](https://cannabisrezept.online) - [Cannabishelden.de](https://cannabishelden.de) Knowledge & News - [Guide](/en/guide) - [Recipes](/en/rezepte) - [News & Politics](/en/news) - [Cannabis Sommelier](/en/cannabis-sommelier) - [Tools](/en/tools) - [Glossary](/en/glossar) - [FAQ](/en/faq) Legal - [Imprint](/en/impressum) - [Privacy policy](/en/datenschutz) - [Install app](/en/installieren) - [Sitemap](/en/sitemap) Contact Questions? Write us at [info@high.space](mailto:info@high.space) © 2026 HighSpace. All rights reserved. For adults 18+ only.